Application 125288
- Type
- BLA
- Sponsor
- BRISTOL MYERS SQUIBB
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | NULOJIX | BELATACEPT | INJECTABLE; INJECTION | 250MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0003-0371 | NULOJIX | BELATACEPT | E.R. Squibb & Sons, L.L.C. | BLA | Current |
| 0003-0371 | NULOJIX | BELATACEPT | E.R. Squibb & Sons, L.L.C. | BLA | Current |
| 0003-0371 | NULOJIX | BELATACEPT | E.R. Squibb & Sons, L.L.C. | BLA | Current |
| 0003-0371 | NULOJIX | BELATACEPT | E.R. Squibb & Sons, L.L.C. | BLA | Current |
| 0003-0371 | NULOJIX | BELATACEPT | E.R. Squibb & Sons, L.L.C. | BLA | Current |